Gassin123Charts

16.9K posts

Gassin123Charts banner
Gassin123Charts

Gassin123Charts

@MrBreakouts

#ASX Mining Charts & Breakout Alerts | Critical Metals Specialist = #Gold #Silver #Copper #Antimony #Uranium #Lithium #REE #IronOre #Oil #BTC #Dow 🧭

sydney Katılım Mayıs 2022
14K Takip Edilen13.1K Takipçiler
Sabitlenmiş Tweet
Gassin123Charts
Gassin123Charts@MrBreakouts·
#ALBO Idiots🤡the Worst $FIN Leaders in Aussie history !!!!!!
Ryan Dally@Ryandally08

#BREAKING A former Treasury official has issued a bombshell warning that Australians could see their actual tax rate rocket to 60 per cent under the CGT changes. Around 34 per cent of Australian adults, or approximately 7.1 to 7.7 million people, currently hold shares outside of their superannuation. The changes mean the top tax rate on gains made on those shares is effectively 47 per cent. The Financial Services Council (FSC) said the new method means Australia faces “potentially the highest effective CGT rate in the OECD” Anthony Albanese and Jim Chalmers want to take 47% of your money for doing absolutely nothing. Albanese wants you to be solely dependent on Government. That way, he ultimately controls you.

English
2
11
43
4.9K
Gassin123Charts retweetledi
Rhythm Biosciences
Rhythm Biosciences@rhythmbiosc·
📢 Clinical Momentum Continues to Build as Rhythm Secures Further Clinician Support for Colostat®. Inc. Senior gastroenterologists and surgeons across Australia. For diagnostics, this is where commercial adoption starts 🦾 $RHY #ASX #Biotech #Diagnostics
English
0
2
3
404
Gassin123Charts
Gassin123Charts@MrBreakouts·
My new #AI Follower Fiend with a big Bot Heart to Share 💞
AussieF.au@AUaussieF

@MrBreakouts Nice one mate, love the call, makes total sense with oil slipping under $90. You reckon we tag $70 soon or get a bounce first?

English
0
0
0
241
Gassin123Charts retweetledi
ScienceFocus
ScienceFocus@ScienceFocusonX·
Reading glasses might be done. The FDA just approved a once-daily eye drop called VIZZ that sharpens near vision in about 30 minutes and keeps it sharp for up to 10 hours. One drop. Each eye. Per day. That's it. The active ingredient is aceclidine, a compound first used back in 1975 to treat glaucoma. Scientists figured out it could be repurposed to gently shrink the pupil, creating a "pinhole effect" that pulls close-up text back into focus, the same trick your eye does when you squint. Unlike Vuity, the 2021 drop that came before it, VIZZ doesn't mess with your focusing muscles. So no blurry distance vision. No brow ache. No weird zoom effect. It was tested across more than 30,000 treatment days with no major complications. Cost is roughly $2 a day. This matters because presbyopia, the age-related slide that hits most people between 40 and 45, already affects more than 120 million Americans. By 2030, the World Health Organization expects around 2 billion people worldwide to have it. LENZ Therapeutics, the maker, started rolling out samples in October. The squint era is ending. Source: Ynetnews, FOX 26 Houston, Yahoo News
ScienceFocus tweet media
English
359
1.6K
7.2K
1.1M